Dr. Lal PathLabs Limited
LALPATHLAB
Rankning i aktier
#4528
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aktiekurs
$20.35
Senast synkroniserad: 2026-10-19
Marknadsvärde
$3.40B
Förändring (1 dag)
-0.86%
Förändring (1 år)
14.21%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Kategori
Healthcare
Antal utestående aktier för Dr. Lal PathLabs Limited (LALPATHLAB)
Antal utestående aktier per June 2026: 167.00M
Enligt de senaste finansiella rapporterna och aktiekursen för Dr. Lal PathLabs Limited är det aktuella antalet utestående aktier 167.00M. I slutet av March 2024 hade företaget 166.47M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Dr. Lal PathLabs Limited (LALPATHLAB) från 2011 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 167.00M | 0.10% |
| 2025 | 166.83M | 0.22% |
| 2024 | 166.47M | 0.15% |
| 2023 | 166.21M | 0.19% |
| 2022 | 165.90M | 0.27% |
| 2021 | 165.46M | 0.22% |
| 2020 | 165.10M | 0.09% |
| 2019 | 164.95M | 0.58% |
| 2018 | 164.01M | 0.52% |
| 2017 | 163.15M | -1.38% |
| 2016 | 165.44M | 0.73% |
| 2015 | 164.24M | 0.00% |
| 2014 | 164.24M | 6.99% |
| 2013 | 153.51M | -7.13% |
| 2012 | 165.29M | 0.00% |
| 2011 | 165.29M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 371.00M | 122.16% |
US
|
|
| 705.30M | 322.35% |
US
|
|
| 143.28M | -14.20% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.87% |
US
|
